9 results
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Embolism • Provoked ... #PE #Pulmonary # ... Embolism #Treatment ... Algorithm #management #hematology
Pulmonary Pathology and Associated Lung Ultrasound Findings
Pneumothorax:
 - No lung sliding/barcode sign
 - Lung point (hard
Pulmonary Pathology ... Embolism (PE): ... massive/submassive PE ... ) POCUS 101 @ ... #POCUS #ultrasound
RV Dilatation in Pulmonary Embolism on POCUS - Parasternal Long Axis

Acute shortness of breath with this
Dilatation in Pulmonary ... Embolism on POCUS ... - Parasternal Long ... suspicious for PE ... #Embolism #POCUS
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Embolism, Pneumothorax ... Exam, POCUS (B-lines ... , lung sliding) ... stacked nebs • PE ... diagnosis #Management #treatment
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... vein thrombosis; PE ... = pulmonary embolism ... Anticoagulation #Management #Hematology ... #Oncology
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Thromboembolic Pulmonary ... embolism Pathophysiology ... 6 months after PE ... Ventilation-perfusion lung ... Bypass Other Treatment
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Infection (sepsis), PE ... Renal Failure Treatment ... #oncology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... Dose ≥ 400 mg per ... starting amiodarone treatment ... embolism - ... macrophages Treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk PE ... , Pulmonary amyloidosis ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... Sjogrens #Syndrome #Rheumatology